The traditional view of memory is of a short-term phase, in which information is held for a few seconds, followed by a transition to long-term memory. These correlate with the two phases of long-term potentiation, an early transient component (E-LTP) and a stronger, more persistent component (L-LTP), for which activation of a cAMP-dependent protein kinase (PKA) and novel protein synthesis is required. This process appears to be regulated by a phosphatase cascade, in which PKA initially activates dephosphorylase inhibitor 1 (I-1) which in turn inhibits protein phosphatase 1. In contrast, the phosphatase calcineurin, which is also expressed in high levels in the hippocampus, inhibits I-1 and thus has antagonistic effects on the phosphatase cascade. The interactive roles of PKA and calcineurin are thus of great interest in the study of memory processes. In two recent companion papers in Cell, 1,2 the role of calcineurin in LTP and memory was explored by the creation of transgenic mice which overexpress a truncated form of the protein, resulting in increased calcium-dependent phosphatase activity in the hippocampus. Training the mice with spatial and visual recognition tasks revealed that they had normal short-term, but defective long-term memory, which could be rescued by increasing the number of tasks. Furthermore, comparison of these transgenic mice with the wild-type animal, using physiological and pharmacological experiments, revealed evidence for a novel, intermediate phase of LTP (I-LTP), which differed from E-LTP by requiring multiple trains for induction, and from L-LTP since it does not require new protein synthesis. Thus, by regulating I-LTP and acting as a gatekeeper for the synaptic induction of L-LTP, calcineurin can inhibit the formation of longterm memory. 
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Atypical antipsychotics, schizophrenia and cortical 5-HT2A receptors
The 5-hydroxytryptamine 2A receptor is increasingly perceived as central to the action of atypical antipsychotic drugs and may play a wider role in genetic susceptibility to psychiatric disorders. However until recently the relationship between the physiology and localization of expression of 5-HT2A in the cortex was unclear. Jakab and Goldman-Rakic, in a recent paper in Proceedings of the National Academy of Sciences, have reconciled these data using light and electron microscope immunocytochemistry. They were able to confirm the post-and presynaptic location of 5-HT2A receptors and demonstrate that pyramidal neurons are the principal site of expression. Furthermore, they were able to show that the laminar pattern of expression of 5-HT2A receptor in the cortex is a result of intracellular segmentation in proximal apical dendrites, rather than expression in alternating neurons. The high concentration of serotonin in these segments suggests that they play a unique role in sensitivity to 5-HT2A ligands, and that the most potent 5-HT2A-mediated actions are confined to these 'hot-spots'. Thus, the proximal apical dendritic shafts may act as gatekeepers to control the flow of information into the soma and consequent cell firing, through 5-HT2A-mediated modulation of ion channels. The authors suggest that this process may play an important role in the regulation of temporal processing of information, including working memory and latent inhibition, by preventing sensory overload and distractibility. This has implications for schizophrenia, since impairment of working memory and distractibility are features of the illness, and is consistent with a role for the 5-HT2A receptor as a susceptibility gene, These findings, together with genetic and pharmacological evidence, also add weight to the hypothesis that 5-HT2A receptors are important in the clinical action of atypical drugs such as clozapine, which may dampen down hyperactive pyramidal cell activity and relieve psychotic symptoms.
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